Pulmonary Hypertension Care Centers
The Pulmonary Hypertension Association’s Scientific Leadership Council, 28 global leaders in the field of pulmonary hypertension, have spearheaded the PHA-Accredited PH Care Centers (PHCC) initiative to establish a program for accreditation of centers with special expertise in pulmonary hypertension (PH), particularly pulmonary arterial hypertension (PAH), to raise the overall quality of care and outcomes in patients with this life-threatening disease.
Why Accreditation is Needed
Once considered rapidly fatal, PAH can now be treated with many medications, all developed in just the past two decades. Despite medical advances, the median time from onset of symptoms to PAH diagnosis is still 1.1 years, and many patients will see three or more different physicians over this period before they are properly diagnosed. Since early 2011, PHA’s Scientific Leadership Council has developed the PHCC initiative to assure outstanding care in pulmonary hypertension.
More Information
The PHA-Accredited PH Care Centers (PHCC) program is an initiative of PHA’s Scientific Leadership Council to accredit centers in the U.S. in order to raise the level of care for individuals with pulmonary hypertension (PH). Accreditation is based on a center’s overall commitment to PH patients, breadth of involved health care professionals and scope of services provided.
How to Find a PH Specialist In the PHCC Network
PHA has created a map to assist in locating a PHCC near you.
Map of accredited PH care centers
PH specialists in the PHCC network also can be found in our Doctors Who Treat PH directory. They will be designated as part of an accredited PH program in your search.
How PH Care Centers Are Expected to Improve Your Medical Care
- Patients are better informed about comprehensive PH care
- Patients have improved access to Centers with expertise in PH
- Patients experience less time between symptom onset and diagnosis
- A medical community better informed about standards of PH care
- Therapies are appropriately used to improve long-term outcomes
- Increased opportunities for collaboration between Centers for clinical care and PH research
The Two Types of Centers
Two types of centers are accredited: Centers of Comprehensive Care (CCC) and Regional Clinical Programs (RCP). Both accredited CCCs and RCPs will have demonstrated a commitment to providing expert-level care based on pulmonary arterial hypertension (PAH) consensus guidelines.
Centers of Comprehensive Care
A PHA-Accredited Center of Comprehensive Care is a highly organized, full-time PH Center that proficiently evaluates PH patients based on published evidence-based guidelines and also provides expert treatment of pulmonary arterial hypertension (PAH) patients with all of the FDA-approved therapies. CCCs also make important contributions to PH research and education.
Regional Clinical Programs
A PHA-Accredited Regional Clinical Program is a regional PH Center that proficiently evaluates PH patients based on published evidence-based guidelines and also provides expert treatment of PAH patients with all non-parenteral therapies. An RCP must collaborate with its regional CCCs by referring patients that may benefit from opportunities unavailable at the RCP, including the initiation of advanced parenteral therapies and participation in clinical research protocols.
Developing and Implementing the PHCC Program
In September 2011, members of the PHA Board of Trustees, the PHA Scientific Leadership Council, and other key stakeholders in the PH community approved the PHCC initiative in concept. A steering committee and task forces were organized and staffed to address accreditation criteria, program implementation, registry development, communication to key stakeholders and financial sustainability. The members below provided valuable contributions, which include: researching, accumulating and documenting information, developing logic models, defining action steps, building financial projections and validating the program content.
| Murali Chakinala, MD (PHCC Chair) | Washington University in Saint Louis |
| Rino Aldrighetti | PHA |
| Richard Channick, MD | Harvard Medical School |
| C. Gregory Elliott, MD | University of Utah |
| Serpil Erzurum, MD | The Cleveland Clinic Foundation |
| Karen Fagan, MD | University of South Alabama |
| Bob Gray | PHA |
| Michael Patrick Gray, MPH | PHA |
| Carl Hicks | PHA |
| Wendy Hill, RN, MSN | VA Greater LA Healthcare System |
| Steven Kawut, MD, MS (Patient Registry Task Force Chair) | University of Pennsylvania |
| Vallerie McLaughlin, MD | University of Michigan |
| Stephen Mathai, MD, MHS | Johns Hopkins University |
| Olivia Onyeador, MHA | PHA |
| Ron Oudiz, MD (Criteria Task Force Chair) | Harbor UCLA Medical Center |
| Abby Poms, RRT, RCP (Implementation Task Force Co-Chair) | Duke University |
| Jeffrey Sager, MD, MSCE | Cottage Hospital |
| Robert Schilz, DO, PhD | Case Western Reserve University |
| Traci Stewart, RN, MSN | University of Iowa |
| Darren Taichman, MD | University of Pennsylvania |
| Victor Tapson, MD | Cedars-Sinai |
| Corey Ventetuolo, MD, MS | Brown University |
| Joel Wirth, MD (Implementation Task Force Co-Chair) | Maine Medical Center |
| Roham Zamanian, MD (Funding Task Force Chair) | Stanford University |
PHCC Initiative Mission Statement
The purpose of the PHA-Accredited Pulmonary Hypertension Care Centers (PHCC) initiative is to establish a program of accredited centers with expertise in pulmonary hypertension that aspires to improve overall quality of care and ultimately improve outcomes of patients with pulmonary hypertension, particularly pulmonary arterial hypertension, a rare and life-threatening group of diseases.
Why the Need for Accreditation?
Despite the availability and success of PAH-targeted therapeutic options over the past two decades, there are still shortcomings with the diagnosis and management of PAH. One recent study observed that expert recommended diagnostic algorithms were not being followed to completion in up to 94% of PAH patients, and nearly 60% of PAH referrals to expert centers already on therapy were on so contrary to published guidelines. In addition, despite the available medical therapies, long-term outcomes are still not optimal as many patients still die from PH, require transplantation or require hospitalization.
PH Care Centers: What You Need to Know
Two types of centers are be accredited: Centers of Comprehensive Care (CCC) and Regional Clinical Programs (RCP). Please note that applications for Pediatric Regional Clinical Programs are not currently being accepted. Learn more about the PH Care Centers initiative:
- Application Process
- Accreditation Criteria
- Frequently Asked Questions
- Informational Webinars
- PHCC Medical Leadership
- Get Involved
PHCC News and Research
Advisory: Reproductive Health and Pulmonary Hypertension
Pregnancy is considered high risk for people with pulmonary hypertension because their heart and lungs can’t easily adjust to the demands of pregnancy and childbirth.
Summit Explores Ways to Improve Care Access, Research for Underserved Communities
A recent associated disease summit brought together the rare disease community to discuss challenges in increasing disease awareness and clinical trials participation among underserved communities. The summit, organized by the Pulmonary Hypertension Association, included representatives from 34 organizations.
How PHA Spread Awareness in November
Throughout November, the Pulmonary Hypertension Association shared the stories of people who “Live PHearlessly” to raise awareness of pulmonary hypertension. More than 30 people with PH participated, including Esther Liu, Wendy McBride and Jamie Mykins. Others, such as Amy Burant and Nancy Zeppa, advocated for improved oxygen access by sharing their experiences. See their stories.
PH Professionals: Share Your Expertise at PHA 2024
The Pulmonary Hypertension Association is accepting abstract and speaker proposals for PHA 2024 International PH Conference and Scientific Sessions, Aug. 15-18, 2024, in Indianapolis. Submit your proposals by Jan. 19, 2024. Learn more.
Support Group Leaders Discuss 2024 Plan
PHA’s Support Group Leader Advisory Board recently convened in-person for the first time in-person since 2019. The advisory board met Nov. 5 in Washington, D.C., where members discussed support group programming for PHA 2024 International PH Conference and Scientific Sessions, as well volunteer training and appreciation. Learn more.
Thank You for Your Generosity on GivingTuesday
Your GivingTuesday investment in our mission made a big impact. Together, we raised more than $85,000 through 180 individual donations and a $35,500 matching gift from PHA’s Kitchen Table Society. Learn more.
Learn How PH Associations Have Enhanced Patient Care
Pulmonary Hypertension Association CEO Matt Granato is among the speakers in the next Alliance for Pulmonary Hypertension webinar. The webinar is set for 12:30 p.m. EST Tuesday, Dec. 12. The webinar will provide a historical overview of pulmonary hypertension-related associations and their role in patient care and support. Learn more.
4 Stories of Living PHearlessly Around the World
As we celebrate Pulmonary Hypertension Awareness Month, we’re sharing the stories of people who commit to “Live PHearlessly” with pulmonary hypertension. In this issue, we focus on people from Australia, England, Nigeria and Spain. Read their stories.
Now Online: PHA Journal Focuses on Group 2 PH
The latest issue of Advances in Pulmonary Hypertension addresses Group 2 pulmonary hypertension, the most common cause of PH in the developed world. Caused by left heart disease, Group 2 PH has many diagnostic and therapeutic challenges. Learn more.
Carter-Hicks’ Holiday Cabaret to Benefit PHA
Join the Washington, D.C.-area pulmonary hypertension community for a holiday performance by Stephen Carter-Hicks. The holiday cabaret, set for 7:30 p.m. EST, Tuesday, Dec. 5, will benefit the Pulmonary Hypertension Association. Carter-Hicks, a longtime PHA volunteer and professional entertainer, will take you over the river and through the woods with secular and sacred Christmas songs. Learn more.
Fundraising Walks Wrap Up Until 2024
As Pulmonary Hypertension Awareness Month winds down, PHA is grateful for the support it receives through fundraising events, such as three O2breathe walks that took place in November. The walks were the last three of this year, but we look forward to more in 2024. Read more.
ABIM Webinar Features PHA Leaders
In honor of Pulmonary Hypertension Awareness Month in November, ABIM partnered with the Pulmonary Hypertension Association to offer a webinar featuring PH physicians, PHA President and CEO Matt Granato and Colleen Connor, PHA board member and patient representative on ABIM’s Pulmonary Disease Board. Watch the webinar.
Why You Should Become a PHA Professional Member
Tina Styer, RN, BSN, enjoys and expanded network of pulmonary hypertension professionals, thanks to her Pulmonary Hypertension Association membership. “PHA professional membership has allowed me to meet new people … that I now consider close friends,” says Styer. Join Styer as a PHA professional member before Dec. 18 to receive 20% off membership.
The Case for Portable Liquid Oxygen
Transitioning to liquid oxygen was challenging. My oxygen needs increased requiring me to learn a new system. This change forced me to admit that my progressive disease was progressing.
Oxygen Users ‘Desperately Need More Options’
Nancy Zeppa, 60, is a leader of the Pulmonary Hypertension Association South Jersey Support Group. Her journey with oxygen began in August 2019 when she was diagnosed with pulmonary arterial hypertension.
How Ron Ancrum Found Strength to ‘Keep On Moving’
Ron Ancrum was 25 when he learned he had sarcoidosis. Three decades later, he learned the condition had caused pulmonary arterial hypertension. He shares his path to positivity and self-publishing in the Pulmonary Hypertension Association’s Right Heart Blog. Read his story.
PH Community Shows How They ‘Live PHearlessly’
Living with pulmonary hypertension creates plenty of challenges, but it doesn’t stop people from doing what they love. Lakeisha Orr is one of several people who find the strength to enjoy the outdoors. She and others are sharing their stories as part of the Pulmonary Hypertension Association’s PH Awareness Month campaign, “Live PHearlessly.”
New Webinars to Address Promising PH Treatments, Clinical Trials
Join the Pulmonary Hypertension Association and Fundación Contra la Hipertensión Pulmonar for a two-part webinar series, “Hope Through Research in Pulmonary Hypertension.”
PTE Surgery Discovers a ‘Young Heart’
Mark Porter, 49, lives in Rexburg, Idaho, with Erin, his wife of 26 years. They have three sons, Colton, Carson and Caleb. Mark owns Porter’s Office Products and enjoys working out, skiing and water skiing. He originally shared his story in the winter 2022 issue of Pathlight, the Pulmonary Hypertension Association’s member magazine.